Four in 10 patients with aggressive lymphoma were cancer-free 15 months after treatment with engineered immune cells, according to new clinical trial results.
Combining two different immunotherapy treatments could dramatically improve lymphoma survival.
Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.
This week saw new research on brain tumour and ovarian cancers, while MPs launched an inquiry into e-cigarettes.
A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.
In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.
Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment
A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.
New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.